SNCA Gene Dementia Lewy Body Genetic Test Price 4400 AED
SNCA Gene Dementia Lewy Body Test in the UAE
Dementia Lewy body (DLB) is a type of dementia that can lead to memory impairment, movement disorders, and cognitive fluctuations. If you’re in the UAE and apprehensive about DLB due to a familial history of the condition, the SNCA Gene Dementia Lewy Body Test can serve as a significant resource for your doctor to evaluate your risk of contracting the disease.
Comprehending Dementia Lewy Body (DLB):
DLB is instigated by unusual protein deposits known as Lewy bodies in the brain. These Lewy bodies can influence brain cells, resulting in symptoms like memory impairment, concentration difficulties, movement issues, and mood and behavior alterations.
Genetics and DLB:
While the precise cause of DLB remains elusive, studies indicate that genetics may contribute in certain cases. The SNCA gene is responsible for producing a protein called alpha-synuclein. Mutations (alterations) in this gene have been associated with a heightened risk of developing DLB.
What is the SNCA Gene Dementia Lewy Body Test?
This test scrutinizes your DNA to detect specific mutations in the SNCA gene. It’s crucial to note that this is not a diagnostic test for DLB, but rather an instrument to evaluate your genetic risk.
Advantages of the SNCA Gene Dementia Lewy Body Test:
Risk Evaluation: A positive test result can signify an increased risk of developing DLB, particularly if you have a family history of the condition. This information can assist with future planning and early intervention strategies. Informed Choices: Being aware of your genetic risk enables you and your doctor to make informed choices about monitoring your cognitive health and potentially participating in clinical trials for future treatments. Family Planning: If you have a family history of DLB and are contemplating having children, genetic counseling can be beneficial in understanding the implications of this test result.
Who Stands to Gain from the SNCA Gene Dementia Lewy Body Test?
This test may be considered for individuals with:
A close relative diagnosed with DLB. A family history suggestive of DLB, even if a specific diagnosis hasn’t been confirmed in a family member. Unexplained symptoms that raise concern for DLB, such as memory loss, movement difficulties, and fluctuations in thinking.
What Can You Anticipate During the Test?
The SNCA Gene Dementia Lewy Body Test typically involves a straightforward cheek swab or blood draw. There’s typically no special preparation needed.
Interpreting the Results:
A positive test result signifies the presence of a specific mutation in the SNCA gene, but it doesn’t guarantee you will develop DLB. Many people with this mutation never experience symptoms. Conversely, a negative test result doesn’t completely rule out DLB, as other genetic and non-genetic factors can also play a role.
Genetic Counseling is Essential
This test is a complex one, and genetic counseling is highly recommended before and after the test. A genetic counselor can explain the test results in detail, address any concerns you may have, and guide you through the implications based on your specific situation.
Proactively Managing Your Brain Health
If you’re worried about DLB, discussing the SNCA Gene Dementia Lewy Body Test with your doctor in the UAE can be a vital move towards understanding your risk profile. Early planning and proactive measures can significantly enhance your quality of life and well-being.
Components:
SNCA Gene Dementia Lewy Body Genetic Test
Price:
4400.0 AED
Sample Condition:
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery:
3 to 4 Weeks
Method:
NGS Technology
Test Type:
Neurological Disorders
Doctor:
Neurologist
Test Department:
Genetics
Pre Test Information:
Clinical History of Patient who is going for SNCA Gene Dementia, Lewy body NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SNCA Gene Dementia, Lewy body.
Test Details:
The SNCA gene is associated with the development of Lewy body dementia, a type of dementia that is characterized by the accumulation of abnormal protein deposits in the brain. NGS (next-generation sequencing) genetic testing is a method of DNA analysis that can be used to identify mutations or variations in the SNCA gene that may increase the risk of developing Lewy body dementia. NGS genetic testing involves the sequencing of DNA fragments using high-throughput technologies, which enables the analysis of large amounts of genetic data in a short period of time. This type of testing can be used to identify mutations or variations in the SNCA gene that may increase the risk of developing Lewy body dementia. NGS genetic testing can also be used to identify other genetic factors that may contribute to the development of dementia, such as mutations in the APOE gene, which is associated with an increased risk of developing Alzheimer’s disease. Genetic testing can help individuals and their families understand their risk of developing dementia, and may also inform treatment and management decisions. However, it is important to note that genetic testing cannot predict the onset or severity of dementia with certainty, as many other factors also contribute to the development of the disease.
| Test Name | SNCA Gene Dementia Lewy body Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SNCA Gene Dementia, Lewy body NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SNCA Gene Dementia, Lewy body |
| Test Details | The SNCA gene is associated with the development of Lewy body dementia, a type of dementia that is characterized by the accumulation of abnormal protein deposits in the brain. NGS (next-generation sequencing) genetic testing is a method of DNA analysis that can be used to identify mutations or variations in the SNCA gene that may increase the risk of developing Lewy body dementia. NGS genetic testing involves the sequencing of DNA fragments using high-throughput technologies, which enables the analysis of large amounts of genetic data in a short period of time. This type of testing can be used to identify mutations or variations in the SNCA gene that may increase the risk of developing Lewy body dementia. NGS genetic testing can also be used to identify other genetic factors that may contribute to the development of dementia, such as mutations in the APOE gene, which is associated with an increased risk of developing Alzheimer’s disease. Genetic testing can help individuals and their families understand their risk of developing dementia, and may also inform treatment and management decisions. However, it is important to note that genetic testing cannot predict the onset or severity of dementia with certainty, as many other factors also contribute to the development of the disease. |
